Search results
Author(s):
Phong Phan Dinh
,
Tri Huynh Quang Ho
,
Hung Manh Pham
,
et al
Added:
1 year ago
Author(s):
Added:
8 months ago
ERA 2025 - Results from a meta-analysis of trials including EMPA-KIDNEY show the treatment effect of empagliflozin is not modified by level of predicted acute eGFR dip.Dr Natalie Staplin (University of Oxford, Oxford, UK) joins us to discuss findings from a meta-analysis of four trials, including the EMPA-KIDNEY trial (NCT03594110), investigating the impact of acute eGFR dips and markers of…
View more
Richard Solomon
Job title: Professor of Medicine
Author
Author(s):
James Udelson
Added:
11 months ago
THT Conference 2025 - Positive safety and efficacy outcomes were found of the Reprieve decongestion management system (DMS; Reprieve Cardiovascular, Inc) for the treatment of acute decompensated heart failure (ADHF). Urinary sodium excretion was seen to be significantly higher in the Reprieve DMS arm than in the control arm, and there were fewer UTI infections in ADHF patients receiving the…
View more
Author(s):
Joost Daemen
,
Allen Jeremias
,
Ziad A Ali
Added:
2 years ago
Join us for an informative video that explores the innovative approach of performing zero-contrast percutaneous coronary intervention (PCI) using advanced medical technologies and best practices. In recent years, contrast supply shortages and the need for improved patient outcomes have presented significant challenges in care delivery. In this video, our esteemed faculty will demonstrate the…
View more
Expert Insights from ERA 2025
Video Series
Author(s):
Daniel Murphy
,
Debasish Banerjee
Added:
6 months ago
Lorenzo Azzalini
Job title: Director of Interventional Cardiology Research and Associate Professor of Medicine
Author
Author(s):
Felix Böhm
Added:
1 year ago
ACC.24 — Investigator, Dr Felix Böhm (Danderyd Hospital, SE) joins us to discuss the findings from a study investigating fractional flow reserve-guided complete or culprit-only percutaneous coronary intervention (PCI) in patients with ST-elevation myocardial infarction (MI).1542 patients were enrolled in the trial, who were randomized 1:1 to receive either FFR-guided PCI of non-culprit lesions…
View more
AF Symposium 2024 Late-Breaking Science Collection
Video Series